ZA815541B - Heterocyclic compounds - Google Patents
Heterocyclic compoundsInfo
- Publication number
- ZA815541B ZA815541B ZA815541A ZA815541A ZA815541B ZA 815541 B ZA815541 B ZA 815541B ZA 815541 A ZA815541 A ZA 815541A ZA 815541 A ZA815541 A ZA 815541A ZA 815541 B ZA815541 B ZA 815541B
- Authority
- ZA
- South Africa
- Prior art keywords
- heterocyclic compounds
- heterocyclic
- compounds
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/44—Iso-indoles; Hydrogenated iso-indoles
- C07D209/48—Iso-indoles; Hydrogenated iso-indoles with oxygen atoms in positions 1 and 3, e.g. phthalimide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
- C07D209/14—Radicals substituted by nitrogen atoms, not forming part of a nitro radical
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
- C07D209/14—Radicals substituted by nitrogen atoms, not forming part of a nitro radical
- C07D209/16—Tryptamines
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
- C07D209/18—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Heart & Thoracic Surgery (AREA)
- Pain & Pain Management (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Cardiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Indole Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB8026287 | 1980-08-12 |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA815541B true ZA815541B (en) | 1983-03-30 |
Family
ID=10515411
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA815541A ZA815541B (en) | 1980-08-12 | 1981-08-11 | Heterocyclic compounds |
Country Status (5)
Country | Link |
---|---|
US (1) | US4839377A (xx) |
JP (1) | JPS5759865A (xx) |
BE (1) | BE889931A (xx) |
CA (1) | CA1165765A (xx) |
ZA (1) | ZA815541B (xx) |
Families Citing this family (32)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5225431A (en) * | 1987-10-23 | 1993-07-06 | Burroughs Wellcome Co. | Therapeutic substituted indole compounds and compositions thereof |
RU2160736C2 (ru) * | 1990-06-07 | 2000-12-20 | Зенека Лимитед | Производные индола и их физиологически приемлемые соли и сольваты, способы их получения, лекарственное средство для лечения или профилактики клинических состояний, для которых показан прием агониста "5-нт1-подобного" рецептора, и способ его получения |
EP0592438B1 (en) * | 1990-10-15 | 1997-08-27 | Pfizer Inc. | Indole derivatives |
US5317103A (en) * | 1991-01-15 | 1994-05-31 | Merck Sharp & Dohme Limited | Indole-substituted five-membered heteroaromatic compounds as 5-HT1 agonists |
CZ283018B6 (cs) * | 1991-02-01 | 1997-12-17 | Merck Sharp And Dohme Limited | Deriváty imidazolu, triazolu a tetrazolu a farmaceutické přípravky na jejich bázi |
TW263504B (xx) | 1991-10-03 | 1995-11-21 | Pfizer | |
DK0619805T3 (da) * | 1991-11-25 | 2000-06-05 | Pfizer | 5-(Hetero-eller carbocyclylamino)-indolderivater, deres fremstilling og anvendelse som 5-HT1-agonister |
TW288010B (xx) * | 1992-03-05 | 1996-10-11 | Pfizer | |
RU2101283C1 (ru) | 1992-04-07 | 1998-01-10 | Пфайзер Инк. | Производные индола или их фармацевтически приемлемые соли |
US6380233B1 (en) | 1992-04-07 | 2002-04-30 | Pfizer Inc | Indole derivatives as 5-HT1 agonists |
ATE148465T1 (de) * | 1992-04-10 | 1997-02-15 | Pfizer | Acylaminoindolderivate als 5-ht1 agonisten |
GB9207930D0 (en) * | 1992-04-10 | 1992-05-27 | Pfizer Ltd | Indoles |
IL106445A (en) * | 1992-07-30 | 1998-01-04 | Merck Sharp & Dohme | History of 1,2,4-Trans-Triazole 4-Transform, Preparation and Pharmaceutical Preparations Containing Them |
TW251284B (xx) * | 1992-11-02 | 1995-07-11 | Pfizer | |
EP0804434A1 (en) * | 1994-08-02 | 1997-11-05 | MERCK SHARP & DOHME LTD. | Azetidine, pyrrolidine and piperidine derivatives |
FR2731224B1 (fr) * | 1995-03-02 | 1997-05-30 | Pf Medicament | Nouveaux derives bi-tryptaminiques sulfonamides, leur procede de preparation et leur utilisation a titre de medicaments |
WO1997000244A1 (en) * | 1995-06-19 | 1997-01-03 | Eli Lilly And Company | Process for parallel synthesis of a non-peptide library |
US5942536A (en) * | 1995-10-10 | 1999-08-24 | Eli Lilly And Company | N- 2-substituted-3-(2-aminoethyl)-1H-indol-5-YL!-Amides: new 5-HT1F agonists |
AU2003249583B2 (en) | 2002-06-21 | 2007-06-07 | Suven Life Sciences Limited | Novel tetracyclic arylcarbonyl indoles having serotonin receptor affinity useful as therapeutic agents, process for their preparation and pharmaceutical compositions containing them |
DK1537113T5 (da) * | 2002-06-21 | 2011-01-10 | Suven Life Sciences Ltd | Arylalkylindoler med serotoninreceptoraffinitet anvendelige som terapeutiske midler, fremgangsmåde til fremstilling heraf og farmaceutiske sammensætninger indeholdende disse |
CA2490254C (en) * | 2002-06-21 | 2011-11-01 | Suven Life Sciences Limited | Novel tetracyclic arylsulfonyl indoles having serotonin receptor affinity useful as therapeutic agents, process for their preparation and pharmaceutical compositions containing them |
BRPI0315958B8 (pt) * | 2002-11-28 | 2021-05-25 | Suven Life Sciences Ltd | composto, composição farmacêutica, processo para a preparação de um composto, novos intermediários e uso do composto |
NZ572186A (en) * | 2002-11-28 | 2010-02-26 | Suven Life Sciences Ltd | N-arylsulfonyl-3-substituted indoles having serotonin receptor affinity, process for their preparation and pharmaceutical composition containing them |
PT1581538E (pt) * | 2002-12-18 | 2007-05-31 | Suven Life Sciences Ltd | Indolos tetracíclicos substituidos na posição 3 que possuem afinidade pelo receptor de serotonina. |
KR20130136010A (ko) * | 2005-04-13 | 2013-12-11 | 네우렉슨 인코포레이티드 | Nos 저해 활성을 갖는 치환된 인돌 화합물 |
JP5350219B2 (ja) * | 2006-04-13 | 2013-11-27 | ニューラクソン,インコーポレーテッド | Nos阻害活性を有する1,5および3,6−置換インドール化合物 |
US20080234355A1 (en) * | 2006-09-11 | 2008-09-25 | Xiong Cai | Dna methyl transferase inhibitors containing a zinc binding moiety |
US8063094B2 (en) * | 2007-02-08 | 2011-11-22 | Boehringer Ingelheim International Gmbh | Anti-cytokine heterocyclic compounds |
WO2009064505A1 (en) * | 2007-11-16 | 2009-05-22 | The Arizona Board Of Regents On Behalf Of The University Of Arizona | Methods for treating visceral pain |
NZ586082A (en) | 2007-11-16 | 2013-03-28 | Neuraxon Inc | Indole compounds and methods for treating visceral pain |
EP2220074A4 (en) * | 2007-11-16 | 2012-01-04 | Neuraxon Inc | 3,5-SUBSTITUTED INDOL COMPOUNDS WITH NOS AND NOREPINEPHRINE RECOVERY-HEMDERING EFFECT |
KR101534136B1 (ko) * | 2013-06-11 | 2015-07-07 | 이화여자대학교 산학협력단 | 인돌 유도체 또는 이의 약학적으로 허용가능한 염, 이의 제조방법 및 이를 유효성분으로 포함하는 5-ht6 수용체 관련 질환의 예방 또는 치료용 약학적 조성물 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR1203195A (fr) * | 1958-07-25 | 1960-01-15 | Chimiotherapie Lab Franc | Procédé de préparation d'un nouveau dérivé de la tryptamine |
NL7316677A (xx) * | 1972-12-21 | 1974-06-25 | ||
ZA795239B (en) * | 1978-10-12 | 1980-11-26 | Glaxo Group Ltd | Heterocyclic compounds |
-
1981
- 1981-08-11 BE BE0/205644A patent/BE889931A/fr not_active IP Right Cessation
- 1981-08-11 ZA ZA815541A patent/ZA815541B/xx unknown
- 1981-08-12 JP JP56125413A patent/JPS5759865A/ja active Granted
- 1981-08-12 CA CA000383680A patent/CA1165765A/en not_active Expired
-
1987
- 1987-08-06 US US07/082,132 patent/US4839377A/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
JPS5759865A (en) | 1982-04-10 |
US4839377A (en) | 1989-06-13 |
CA1165765A (en) | 1984-04-17 |
BE889931A (fr) | 1982-02-11 |
JPH0148896B2 (xx) | 1989-10-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB2078719B (en) | Heterocyclic compounds | |
DE3172252D1 (en) | Heterocyclic compounds | |
ZA815539B (en) | Heterocyclic compounds | |
JPS56154464A (en) | Heterocyclic compound | |
GB2119801B (en) | Heterocyclic compounds | |
ZA815541B (en) | Heterocyclic compounds | |
GB8315564D0 (en) | Heterocyclic compounds | |
ZA815540B (en) | Heterocyclic compounds | |
JPS56139484A (en) | Heterocyclic compound | |
JPS5791986A (en) | Heterocyclic compounds | |
ZA828304B (en) | Heterocyclic compounds | |
GB2083463B (en) | Heterocyclic compounds | |
GB8300095D0 (en) | Heterocyclic compounds | |
PT76791A (en) | Heterocyclic compounds | |
GB2083476B (en) | Heterocyclic compounds | |
GB2082175B (en) | Heterocyclic compounds | |
PT75828A (en) | Heterocyclic compounds | |
ZA813354B (en) | Heterocyclic compounds | |
DE3377060D1 (en) | Heterocyclic compounds | |
GB8325760D0 (en) | Heterocyclic compounds | |
ZA818703B (en) | Heterocyclic compounds | |
ZA834032B (en) | Heterocyclic compounds | |
GB8308866D0 (en) | Heterocyclic compounds | |
GB8304744D0 (en) | Heterocyclic compounds | |
ZA831466B (en) | Heterocyclic compounds |